Mayne Pharma Group Ltd (ASX:MYX)
A$ 4.58 -0.05 (-1.08%) Market Cap: 389.64 Mil Enterprise Value: 279.18 Mil PE Ratio: 0 PB Ratio: 0.83 GF Score: 75/100

Half Year 2023 Mayne Pharma Group Ltd Earnings Call Transcript

Feb 27, 2023 / 10:00PM GMT
Release Date Price: A$3.15
Operator

Thank you for standing by, and welcome to the Mayne Pharma Group Limited Half Year 2023 Results Briefing. (Operator Instructions) I will now hand the conference over to Mr. Shawn Patrick O'Brien, CEO. Please go ahead.

Shawn Patrick Oâ;Brien
Mayne Pharma Group Limited - CEO, MD & Director

Thank you. And apologies, everyone, for the technical difficulties. We had to try 3 different ways to get connected here. So sorry for the delay.

Good day, and welcome to the Mayne Pharma half year results conference call. At this time, I'm taking over the conference call with myself, CEO and Managing Director of Mayne Pharma; and my colleague here, Aaron Gray, our Chief Financial Officer. Based on the feedback from our investors, this presentation has a lot more information included than normal. We will not be covering the details of every slide, but wanted you to have a comprehensive depth for your reference going forward.

The next slide, please, is our disclaimer slide, and I'll leave that for you to review. And Slide 3, as announced

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot